No Carolina / NY / Florida
Ph: 561.316.3330

No Carolina | NY | Florida

Carestream Health Earned 70 New Patents In 2024

Editor: What To Know

  • Carestream Health earned 70 new patents in medical imaging in 2020 for advances in digital radiography, mobile imaging X-ray systems, and other healthcare technology areas.
  • “Carestream's 2020 patents are 70 more proof points of our ability to develop pioneering digital imaging technologies that meet the evolving medical imaging needs of our customers worldwide,” said Eugene Shkurko, Intellectual Property Counsel at Carestream.
  • Carestream's broad product portfolio includes 2D and 3D digital medical imaging systems for general radiology and specialty areas such as pediatrics and orthopaedics (see video link), as well as digital laser imagers that output medical images to film.

Carestream Health earned 70 new patents in medical imaging in 2020 for advances in digital radiography, mobile imaging X-ray systems, and other healthcare technology areas. Carestream Health notes that twenty-seven of the patents were awarded by the U.S. Patent and Trademark Office; an additional 43 patents were received in European and Asian countries.

“Carestream’s 2020 patents are 70 more proof points of our ability to develop pioneering digital imaging technologies that meet the evolving medical imaging needs of our customers worldwide,” said Eugene Shkurko, Intellectual Property Counsel at Carestream. “Our research and development team continually pursues innovations that have the potential to improve the delivery of care to benefit both patients and providers.”

Patents earned by Carestream’s scientists and engineers in 2020 include:

  • Technology advances in Carestream’s growing portfolio of radiology imaging detectors with processing capabilities to calibrate and correct X-ray images in the detector before transmission
  • 3-D image reconstruction methods
  • New medical image capture technologies related to long-length imaging using a single X-ray exposure for full spinal and extremity imaging; and
  • Mobile X-ray cart technology that enables bedside imaging in selectable modes: projection radiography, tomosynthesis and fluoroscopy.

Carestream’s broad product portfolio includes 2D and 3D digital medical imaging systems for general radiology and specialty areas such as pediatrics and orthopaedics (see video link), as well as digital laser imagers that output medical images to film.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Recent News

VeraClinic: Pioneering Personal Transformation Through Hair Transplantation and Cosmetic Surgery in Turkey

As a testament to Turkey's legacy in the world of aesthetic medicine, VeraClinic invites you to discover the transformative power of our hair transplantation and cosmetic surgery services.

CV Societies Propel Plans Forward for a New Board of Cardiovascular Medicine

“The open comment period is the time for cardiovascular physicians, allies in other medical specialties, patients, and others to make their voices heard on why an independent CV Board is the best path for cardiologists to stay up-to-date on best practices and evidence-based care, ensuring patients receive the best possible care,” said Jeffrey Kuvin, MD, president of the proposed Board’s new Board of Directors. “The field of cardiovascular medicine has evolved dramatically over the past few decades; now is the right time to develop an independent cardiovascular Board.”

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

Sang-ki Oh, CEO of Hyundai Bioscience, stated, "Niclosamide-based metabolic anticancer drug candidate will be the first P53-targeting anticancer treatment that selectively kills p53 mutated cancer cells," and added, "Through our subsidiary ADM Korea, we plan to conduct clinical trials targeting cancer patients with intractable cancer caused by p53 mutations, which will be the first step of clinical development on niclosamide-based anticancer agent pipeline."
Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

About Medical Device News Magazine

About Medical Device News Magazine. A digital publication founded in 2008 located in the United States. The publication is one of the industry’s leading sources of medical device and biotech industry updates. Medical Device News Magazine is easily accessible 24/7/365 and is a fast 1, 2, 3 easy read! Our purpose is...

By using this website you agree to accept Medical Device News Magazine Privacy Policy